Free Trial

Atyr PHARMA (ATYR) Earnings Date, Estimates & Call Transcripts

Atyr PHARMA logo
$3.35 +0.20 (+6.35%)
(As of 12/20/2024 05:31 PM ET)

Atyr PHARMA Latest Earnings Summary

Actual EPS
(Nov. 7)
-$0.23 Missed By -$0.01
Consensus EPS
(Nov. 7)
-$0.22

Atyr PHARMA posted Q3 2024 earnings on November 7, 2024, reporting an EPS of -$0.23, which missed the consensus estimate of -$0.22 by $0.01. With a trailing EPS of -$0.94, Atyr PHARMA's earnings are expected to grow next year, from ($0.89) to ($0.87) per share.

Get Atyr PHARMA Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Atyr PHARMA and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

ATYR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ATYR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Atyr PHARMA Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20241-$0.22-$0.22-$0.22
Q4 20241-$0.24-$0.24-$0.24

Atyr PHARMA Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/7/2024--$0.22-$0.23 -$0.01-$0.23$0.13M-
8/13/2024Q2 2024-$0.24-$0.23+$0.01-$0.23$0.12M-
5/2/2024Q1 2024-$0.24-$0.23+$0.01-$0.23$0.11M$0.24M
3/14/2024Q4 2023-$0.23-$0.25 -$0.02-$0.25--
11/9/2023Q3 2023-$0.21-$0.20+$0.01-$0.20$6.00M$0.35M
8/9/2023Q2 2023-$0.27-$0.22+$0.05-$0.22--
5/9/2023Q1 2023-$0.39-$0.29+$0.10-$0.29--
3/9/2023Q4 2022-$0.48-$0.26+$0.22-$0.26$1.50M$10.39M

Atyr PHARMA Earnings - Frequently Asked Questions

Atyr PHARMA (NASDAQ:ATYR) last announced its quarterly earning data on Thursday, November 7, 2024. Learn more on ATYR's earnings history.

In the previous quarter, Atyr PHARMA (NASDAQ:ATYR) missed the analysts' consensus estimate of ($0.22) by $0.01 with a reported earnings per share (EPS) of ($0.23). Learn more on analysts' earnings estimate vs. ATYR's actual earnings.

Atyr PHARMA (NASDAQ:ATYR) has a recorded annual revenue of $235,000.00.

Atyr PHARMA (NASDAQ:ATYR) has a recorded net income of -$50.39 million. ATYR has generated -$0.94 earnings per share over the last four quarters.

Atyr PHARMA's earnings are expected to grow from ($0.89) per share to ($0.87) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:ATYR) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners